Tuesday

11th May 2021

EU defends its slower vaccine authorisation

  • The procedure followed by the British authorities gives the companies complete immunity from legal liability in civil cases (Photo: Nathan Forget)

"The promise of vaccines is phenomenal [and] the reward is potentially game-changing," World Health Organization (WHO) regional director for Europe Hans Kluge said on Thursday (3 December), as the UK became the first Western country to approve a vaccine.

However, recent WHO studies indicate that about half of the population in some European countries are unsure about vaccination against Covid-19.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

For Kluge, "it's understandable to be concerned about vaccination in the current circumstances in which much is still unknown" - such as which vaccines will eventually be licensed, when they will be available and their potential side effects, if any.

The reassurance comes a day after the UK became the first Western country to approve a vaccine and the first in the world to give the green light to the vaccine jointly developed by US's firm Pfizer and Germany's BioNTech - with the UK's rollout expected to at least begin next week.

The UK's medicines regulatory agency announced the decision on Wednesday, just weeks after the companies released first data from the final stage of their clinical trial.

The procedure followed by the British authorities, however, gives the companies complete immunity from legal liability in civil cases.

The license, known as an "emergency use authorisation," has been traditionally used to allow medical products under emergency conditions which have not been already approved by the European Medicine Agency (EMA).

Under EU law, all member states can opt for this approach.

However, a commission official said on Thursday that for member states, it is important that the vaccine approval goes through the EU agency, since the trust of citizens is at stake.

Nevertheless, Hungary may end up using this opt-out approach for the roll out the Russian-made vaccine Sputnik V.

UK vs EMA

Meanwhile, the EMA is carrying out a fast-track but standardised regulatory process for the approval of two vaccines candidates, developed by Pfizer/BioNTech and Moderna, which have applied for EU-wide authorisation.

Under this approach, the same standards of quality, safety and efficacy for the approval of all EU medicines will apply to Covid-19 vaccines.

The Amsterdam-based agency, which moved from London after Brexit and is responsible for the scientific assessment of the data of all clinical trials, said this is the "most appropriate" method to approve the vaccine.

Data has been examined as it becomes available in order to accelerate the process.

After monitoring the results, EMA has to issue a scientific opinion that the commission uses to discuss with member states and give the official green light to the authorisation.

This final step by the commission, which can take up to 67 days, will be reduced to three days to ensure a quick distribution.

For the Pfizer/BioNTech vaccine, EMA expects to have a scientific opinion no later than 29 December - meaning that distribution could start early January.

The "conditional marketing authorisation" that companies will receive, which is foreseen under public health emergencies, holds the company accountable for the safety of the product - even after the approval is granted.

Moreover, the companies are responsible for monitoring the safety vaccines, reporting suspected adverse reactions to EMA and keeping product information up to date, while conducting safety and effectiveness studies regularly.

Hacked

The commission, on behalf of member states, has sealed deals with Moderna, AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV, BioNTech/Pfizer and CureVac for up to two billion vaccine doses.

The EU executive said that once a vaccine is authorised, EU countries will get access to purchase the vaccines at the same time, on a population-based pro-rata basis.

Member states can also donate the vaccines to lower and middle-income countries or to re-direct it to other neighbouring countries.

Meanwhile, the commission's taxation and customs department has been targeted by hackers who have launched a "global phishing campaign" to gain insights about the Covid-19 vaccine 'cold supply chain', tech giant IBM revealed on Thursday.

Understanding how to build a secure cold chain may be key for the storage and distribution of vaccines like the one of BioNTech/Pfizer, which needs to be stored at minus 70 degrees to avoid spoiling.

EU commission keeps vaccine price secret

The European Commission is about to sign a fourth contract for hundreds of millions of vaccine doses against Covid-19. The contracts include non-disclosure clauses, meaning things like price or even where they will be produced remains confidential.

EU seeks new deal for '90% effective' Covid-19 vaccine

After an experimental Covid-19 vaccine developed by the American giant Pfizer and its German partner BioNTech was found to be more than 90 percent effective, the EU announced that it will sign a contract for up to 300 million doses.

News in Brief

  1. Israeli rockets kill 20 people in Gaza retaliation
  2. No more EU expulsions likely over Russia bomb attacks
  3. EU ready to ignore Hungary veto on Hong Kong
  4. Borrell admits EU neglect of Western Balkans
  5. Macron accused of 'cowardice and deceit' in military letter
  6. EU citizens in UK applying for settled status face legal limbo
  7. Netherlands gives €2bn to offshore carbon storage project
  8. Germany will allow Johnson & Johnson vaccine for all ages

Conservatives' Covid-strategy wins in lockdown-fatigue Madrid

Madrid conservative leader Isabel Diaz Ayuso has become a political phenomenon mainly because of her success in keeping Madrid open during the worst moments of the pandemic. However, critics accuse her of neglecting health services - while only protecting businesses.

Column

The EU needs a global vaccination strategy - right now

The further the vaccination campaign progresses, the more people will ask: what about the rest of the world? The EU should answer the question loud and clear now before it is drowned out by a rising chorus of criticism.

Stakeholders' Highlights

  1. Nordic Council of MinistersNordic Council enters into formal relations with European Parliament
  2. Nordic Council of MinistersWomen more active in violent extremist circles than first assumed
  3. Nordic Council of MinistersDigitalisation can help us pick up the green pace
  4. Nordic Council of MinistersCOVID19 is a wake-up call in the fight against antibiotic resistance
  5. Nordic Council of MinistersThe Nordic Region can and should play a leading role in Europe’s digital development
  6. Nordic Council of MinistersNordic Council to host EU webinars on energy, digitalisation and antibiotic resistance

Latest News

  1. Russia penetrated Merkel's 'inner circle', Khodorkovsky says
  2. First recovery euros could be paid out in July
  3. Commission wants help for Italy after weekend's migrant arrivals
  4. Mercosur trade deal will fuel 'poison pesticides' back into EU
  5. Can new Iran talks avoid mistakes of the original JCPOA?
  6. EU and US urge Israel to defuse Jerusalem violence
  7. Frontex 'mislabelling minors as adults' on Greek islands
  8. Has Albania really met the 15 tests to join the EU? No

Join EUobserver

Support quality EU news

Join us